These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2964127)

  • 1. [Therapy of prostatic cancer with cyproterone acetate].
    Maier U
    Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U
    Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
    Pavone-Macaluso M; Serretta V; Pavone C; Romano C; Daricello G
    Arch Esp Urol; 1989; 42 Suppl 2():197-205. PubMed ID: 2534783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of efficacy of cyproterone acetate monotherapy in prostatic cancer].
    Gurina LI; Iudin SV; Rusakov IG; Bystrov AA
    Urologiia; 2003; (4):25-30. PubMed ID: 12942722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
    Debruyne FM
    Am J Clin Oncol; 1988; 11 Suppl 1():S33-5. PubMed ID: 2968760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
    Borgmann V; al-Abadi H; Nagel R
    Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
    Tunn UW; Goldschmidt AJ; Peter K; Becker M
    Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of symptomatic metastatic prostatic cancer with cyproterone acetate versus orchiectomy: a prospective randomized trial.
    Ostri P; Bonnesen T; Nilsson T; Frimodt-Møller C
    Urol Int; 1991; 46(2):167-71. PubMed ID: 1711250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D; Grall J; Davody P; Cukier J
    Prog Clin Biol Res; 1987; 243A():369-77. PubMed ID: 2958861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
    Jansen JE; Hendriksen ON
    Ugeskr Laeger; 1989 Feb; 151(9):560-1. PubMed ID: 2522257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.
    Schröder FH; Whelan P; de Reijke TM; Kurth KH; Pavone-Macaluso M; Mattelaer J; van Velthoven RF; Debois M; Collette L;
    Eur Urol; 2004 Apr; 45(4):457-64. PubMed ID: 15041109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyproterone acetate (Androcur-depo) in the treatment of inoperable prostatic cancer].
    Stepanov VN; Goriunov VG; Chechenin MG; Sivkov AV; Gubdurakhmanov II
    Urol Nefrol (Mosk); 1995; (6):33-6. PubMed ID: 8686122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of advanced prostate cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1986 Jan; 79(1):33-9. PubMed ID: 2938361
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database.
    Seaman HE; Langley SE; Farmer RD; de Vries CS
    BJU Int; 2007 Jun; 99(6):1398-403. PubMed ID: 17537215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
    Spona J; Lunglmayr G
    Wien Klin Wochenschr; 1980 Jul; 92(14):494-7. PubMed ID: 6933738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer].
    Kawai T; Washizuka M; Takahashi T; Kusuyama H
    Gan To Kagaku Ryoho; 1984 May; 11(5):999-1004. PubMed ID: 6202247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of prostatic cancer].
    J Urol (Paris); 1984; 90(10):619-48. PubMed ID: 6242517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostatic cancer before the age of 50--report of 7 cases].
    Aubert J; Dore B; Irani J; Aubert MN
    Prog Urol; 1991 Jun; 1(3):432-9. PubMed ID: 1726944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.